To further analyze the mechanisms of hUCMSCs- LV-IL-21 therapy for ovarian cancer in mice, we designed an experiment to find out whether the serum cytokines of IL-21, IFN-γ, and TNF-α were changed in the mice treated with hUCMSCs-LV-IL-21. This evidence concerns the gene IFNG and ovarian cancer.